Daily ShareChat: Abano Healthcare
By Jenny Ruth
Abano Healthcare produced a solid first-half result with earnings before interest, tax, depreciation and amortisation (EBITDA) from continuing operations of $9.2 million compared with $6.8 million in the previous first-half, says John Cairns, an analyst at Forsyth Barr.
As a result he has raised his EBITDA forecast for the year ending May from $18.6 million to $19 million but left his valuation unchanged at $6.89 a share.
A key feature was the dental division's EBITDA contribution doubling to $5.2 million which provided confirmation the dental growth strategy through acquisition is gathering momentum, Cairns says.
"The dental business will provide earnings momentum as the international audiology network gains scale."
He is forecasting the Bay International audiology clinics business will be in a cash break-even position within two years. While it is still in its formative stages, it "offers considerable growth prospects in developing audiology clinic networks in Australia and Asia."
Unlike the dental strategy, the audiology growth strategy is focused largely around greenfields clinic openings involving limited upfront capital spending.
While ACC restructuring impacted on referral levels for the brain injury rehabilitation business, the alternative hospital care option is significantly more expensive and there are signs of referrals picking up again, he says.
BROKER CALL: Forsyth Barr rate Abano Healthcare as buy.
Daily ShareChat articles report how the main experts in the market might view a certain share and we provide this commentary as a useful resource for investors. Content on this site does not in any way constitute a recommendation to buy, hold or sell any particular share. Investors should always seek professional advice before making any investment decisions.
Comments from our readers
No comments yet Add your comment:
Related News
Daily ShareChat: Abano Abano operating profit meets guidance at $4.4M, before Bay sale proceeds Daily ShareChat: Abano Healthcare Abano trims full-year profit guidance as ACC referrals drop; dividend maintained Daily ShareChat: Abano Healthcare Abano first-half profit soars on asset sale proceeds Bay Audiology sells NZ arm Daily ShareChat: Abano Healthcare Abano shares leap on sale of NZ audiology business Daily ShareChat: Abano Healthcare
NZX Annoucements for ABA
|
|
Abano Healthcare Group Limited Ordinary Shares
Current quote:
ABA $5.09
Quotes delayed 20 minutes
Price when article published: $5.85
Previous News
Sharemarket News By Email
Stock Quote
At a Glance
| NZX 50 Index |
3093.58 |
 |
11.10 |
| S&P/ASX 200 |
4532.70 |
 |
0.00 |
| Dow Jones Industrials |
10320.10 |
 |
50.60 |
Comment & Analysis
|
“
Now, the government has an economic story to tell.
By reframing as a national savings issue the sterile debates about superannuation, privatisation, private foreign debt levels and the sale of farmland to foreigners, the potential is there to de-fang several political bugbears at once.
There is a compelling simplicity, too, to the [...]
”
Pattrick Smellie More »
|
|
|
|


NZX 15 Index
NZX Announcements
|